|
|
Article: CERVICAL CANCER VACCINE AWAITS APPROVAL BY FDA.(News)
- Article from:
- The Cincinnati Post (Cincinnati, OH)
- Article date:
- May 18, 2006
CopyrightCOPYRIGHT 2006 The Cincinnati Post. All rights reserved. Reproduced with the permission of Dialog LLC by Gale Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: Andrew Bridges Associated Press
WASHINGTON -- A vaccine that blocks infection by four types of human papillomavirus could cut global deaths from cervical cancer by more than two-thirds, its manufacturer said in seeking federal approval.
Merck & Co. wants Food and Drug Administration approval for its Gardasil vaccine against the two of those four types of human papillomavirus, or HPV, believed responsible for about 70 percent of cervical cancer cases.
HPV is the most common sexually transmitted disease, affecting more than 50 percent of sexually active adults. The cervical cancer it can cause kills each year roughly 290,000 women ...